CN Patent

CN105085475B — 一种合成阿格列汀中间体的方法

Assigned to SHANGHAI SYNCORES TECHNOLOGIES Inc · Expires 2019-05-21 · 7y expired

What this patent protects

本发明提供了一种合成中间体V的方法，包括：(a)使化合物I与化合物II在碱性条件下在溶剂中加热反应得到中间体III；(b)中间体III在碱性条件下与化合物IV在溶剂中反应得到中间体V。该中间体V可用于合成阿格列汀。

USPTO Abstract

本发明提供了一种合成中间体V的方法，包括：(a)使化合物I与化合物II在碱性条件下在溶剂中加热反应得到中间体III；(b)中间体III在碱性条件下与化合物IV在溶剂中反应得到中间体V。该中间体V可用于合成阿格列汀。

Drugs covered by this patent

Patent Metadata

Patent number: CN105085475B
Jurisdiction: CN
Classification: —
Expires: 2019-05-21
Drug substance claim: No
Drug product claim: No
Assignee: SHANGHAI SYNCORES TECHNOLOGIES Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.